Free Trial

DexCom (DXCM) Short Interest Ratio & Short Volume

DexCom logo
$75.07 -1.31 (-1.72%)
As of 02:41 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

DexCom Short Interest Data

DexCom (DXCM) has a short interest of 8.49 million shares, representing 2.17% of the float (the number of shares available for trading by the public). This marks a -4.50% decrease in short interest from the previous month. The short interest ratio (days to cover) is 2.4, indicating that it would take 2.4 days of the average trading volume of 3.90 million shares to cover all short positions.

Current Short Interest
8,490,000 shares
Previous Short Interest
8,890,000 shares
Change Vs. Previous Month
-4.50%
Dollar Volume Sold Short
$685.74 million
Short Interest Ratio
2.4 Days to Cover
Last Record Date
July 31, 2025
Outstanding Shares
392,150,000 shares
Short Percent of Float
2.17%
Today's Trading Volume
3,220,174 shares
Average Trading Volume
3,898,924 shares
Today's Volume Vs. Average
83%
Short Selling DexCom?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for DexCom and its competitors with MarketBeat's FREE newsletter.

Get Report
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History

DXCM Short Interest Over Time

DXCM Days to Cover Over Time

DXCM Percentage of Float Shorted Over Time

DexCom Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
7/31/20258,490,000 shares $685.74 million -4.5%2.2%2.4 $80.77
7/15/20258,890,000 shares $753.69 million -15.4%N/A2.5 $84.78
6/30/202510,510,000 shares $917.42 million +12.1%2.7%2.6 $87.29
6/15/20259,380,000 shares $769.07 million -9.9%2.4%2.3 $81.99
5/31/202510,410,000 shares $894.84 million -7.7%2.7%2.5 $85.96
5/15/202511,280,000 shares $966.36 million -1.1%2.9%2.6 $85.67
4/30/202511,410,000 shares $814.45 million +7.5%N/A2.5 $71.38
4/15/202510,610,000 shares $734.53 million -3.6%2.7%2.5 $69.23
3/31/202511,010,000 shares $751.87 million -4.0%2.8%2.7 $68.29
3/15/202511,470,000 shares $810.81 million +16.2%2.9%3 $70.69
2/28/20259,870,000 shares $872.21 million +4.1%2.5%2.7 $88.37
2/15/20259,480,000 shares $844.38 million -3.8%2.4%2.7 $89.07
1/31/20259,850,000 shares $855.28 million +11.8%N/A2.8 $86.83
1/15/20258,810,000 shares $708.32 million +0.1%N/A2.2 $80.40
12/31/20248,800,000 shares $684.38 million -5.7%N/A2.3 $77.77
12/15/20249,330,000 shares $720.18 million +10.8%N/A2.3 $77.19
11/30/20248,420,000 shares $656.68 million -7.7%N/A2 $77.99
11/15/20249,120,000 shares $692.03 million -2.6%N/A2.1 $75.88
10/31/20249,360,000 shares $659.69 million +21.9%N/A2.2 $70.48
10/15/20247,680,000 shares $515.33 million -19.6%N/A1.3 $67.10
9/30/20249,550,000 shares $640.23 million +11.7%N/A1.7 $67.04
9/15/20248,550,000 shares $594.31 million +16.6%N/A1.6 $69.51
8/31/20247,330,000 shares $508.26 million -3.0%N/A1.4 $69.34
8/15/20247,560,000 shares $547.04 million +7.2%N/A1.5 $72.36
7/31/20247,050,000 shares $478.13 million -32.3%N/A1.5 $67.82
7/15/202410,420,000 shares $1.18 billion +1.1%N/A3.8 $113.01
6/30/202410,310,000 shares $1.17 billion +14.4%N/A3.8 $113.38
6/15/20249,010,000 shares $1.04 billion +3.1%N/A3.2 $115.95
5/31/20248,740,000 shares $1.04 billion +12.3%N/A3.2 $118.77
5/15/20247,780,000 shares $1.01 billion -29.9%N/A2.7 $129.71
4/30/202411,100,000 shares $1.41 billion -5.7%N/A3.6 $127.39
4/15/202411,770,000 shares $1.58 billion -19.2%N/A3.9 $134.56
3/31/202414,570,000 shares $2.02 billion -8.2%N/A4.7 $138.70
3/15/202415,870,000 shares $2.07 billion -4.7%N/A5.3 $130.46
2/29/202416,650,000 shares $1.92 billion -2.5%N/A5.4 $115.07
2/15/202417,070,000 shares $2.01 billion -8.0%N/A5.7 $117.69
1/31/202418,560,000 shares $2.25 billion +1.8%N/A5.9 $121.35
1/15/202418,240,000 shares $2.28 billion -0.9%N/A5 $125.00
12/31/202318,410,000 shares $2.28 billion -2.9%N/A4.4 $124.09
12/15/202318,960,000 shares $2.32 billion -0.8%N/A4.1 $122.59
Tax Drain Deadline: Protect Your Wealth Before September 15th (Ad)

On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed professionals, retirees, and high-net-worth savers. But the wealthy aren’t just writing checks. They’re moving fast to protect capital and purchasing power using legal, IRS-compliant strategies. American Alternative Assets just released the Mar-A-Lago Accord, a free guide revealing how to reduce Q3 tax exposure and reposition wealth before it’s drained.tc pixel

Click here to download the guide and protect your assets before Sept 15th.
11/30/202319,120,000 shares $2.21 billion +7.7%N/A3.9 $115.52
11/15/202317,750,000 shares $1.81 billion -15.7%N/A3.4 $102.11
10/31/202321,060,000 shares $1.87 billion +30.7%N/A4.2 $88.83
10/15/202316,110,000 shares $1.23 billion +2.0%N/A3.5 $76.19
9/30/202315,800,000 shares $1.47 billion -1.4%N/A3.8 $93.30
9/15/202316,030,000 shares $1.54 billion -5.3%N/A4.4 $96.35
8/31/202316,920,000 shares $1.71 billion +0.8%N/A5 $100.98
8/15/202316,780,000 shares $1.92 billion +11.9%N/A5.4 $114.51
7/31/202315,000,000 shares $1.87 billion +21.2%N/A5.3 $124.56
7/15/202312,380,000 shares $1.70 billion -0.2%N/A4.7 $137.32
6/30/202312,410,000 shares $1.59 billion -2.4%N/A5 $128.51
6/15/202312,710,000 shares $1.66 billion -10.9%N/A5.3 $130.98
5/31/202314,260,000 shares $1.67 billion -1.4%N/A6.3 $117.26
5/15/202314,460,000 shares $1.73 billion +13.6%N/A6.5 $119.61
4/30/202312,730,000 shares $1.54 billion +5.4%N/A5.4 $121.34
4/15/202312,080,000 shares $1.40 billion -2.7%N/A5.3 $115.70
3/31/202312,410,000 shares $1.44 billion -1.4%N/A5.1 $116.18
3/15/202312,580,000 shares $1.43 billion -2.7%N/A5.1 $113.72
2/28/202312,930,000 shares $1.44 billion -2.0%N/A4.9 $111.01
2/15/202313,190,000 shares $1.59 billion +18.7%N/A5 $120.17
1/31/202311,110,000 shares $1.19 billion -5.6%N/A4.4 $107.09
1/15/202311,770,000 shares $1.28 billion +1.0%N/A4.3 $108.47
12/30/202211,650,000 shares $1.32 billion -7.0%N/A4.2 $113.24
12/15/202212,530,000 shares $1.46 billion -3.4%N/A4.3 $116.24
11/30/202212,970,000 shares $1.51 billion +3.0%N/A4.6 $116.28
11/15/202212,590,000 shares $1.46 billion +5.8%N/A4.5 $116.31
10/31/202211,900,000 shares $1.44 billion -13.1%N/A4.3 $120.78
10/15/202213,690,000 shares $1.33 billion +4.5%N/A4.8 $97.41
9/30/202213,100,000 shares $1.06 billion -14.1%N/A4.8 $80.54
9/15/202215,250,000 shares $1.39 billion +6.3%N/A5.9 $90.98
8/31/202214,350,000 shares $1.18 billion +7.2%N/A5.2 $82.21
8/15/202213,390,000 shares $1.24 billion +10.2%N/A4 $92.30
7/31/202212,150,000 shares $997.27 million +3.5%N/A3.3 $82.08
7/15/202211,740,000 shares $929.10 million -3.0%N/A3.3 $79.14
6/30/202212,100,000 shares $901.81 million -6.9%N/A3.4 $74.53
6/15/202213,000,000 shares $929.63 million +293.9%14.8%3.6 $71.51
5/31/20223,300,000 shares $245.80 million -10.6%N/A3.7 $74.49
5/15/20223,690,000 shares $1.24 billion +10.5%N/A4.5 $334.74
4/30/20223,340,000 shares $1.36 billion -3.2%N/A4.2 $408.58
4/15/20223,450,000 shares $1.70 billion -2.8%3.6%4.4 $492.11
3/31/20223,550,000 shares $1.82 billion +4.1%3.7%4 $511.60
3/15/20223,410,000 shares $1.42 billion +0.6%3.6%4.1 $416.08
2/28/20223,390,000 shares $1.40 billion -1.5%3.5%3.8 $413.91
2/15/20223,440,000 shares $1.44 billion +7.2%3.6%3.8 $417.51
1/31/20223,210,000 shares $1.38 billion -3.3%3.4%3.9 $430.48
1/15/20223,320,000 shares $1.49 billion +8.9%N/A4.2 $447.34
12/31/20213,050,000 shares $1.64 billion -1.9%3.2%4.2 $536.95
12/15/20213,110,000 shares $1.68 billion -12.6%3.3%4.7 $541.29
11/30/20213,560,000 shares $2.00 billion -2.5%3.7%5.9 $562.59
11/15/20213,650,000 shares $2.34 billion +0.3%3.8%6.8 $641.95
Tax Drain Deadline: Protect Your Wealth Before September 15th (Ad)

On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed professionals, retirees, and high-net-worth savers. But the wealthy aren’t just writing checks. They’re moving fast to protect capital and purchasing power using legal, IRS-compliant strategies. American Alternative Assets just released the Mar-A-Lago Accord, a free guide revealing how to reduce Q3 tax exposure and reposition wealth before it’s drained.tc pixel

Click here to download the guide and protect your assets before Sept 15th.
10/29/20213,640,000 shares $2.27 billion +4.6%3.8%6.9 $623.21
10/15/20213,480,000 shares $1.89 billion +1.5%3.7%6.2 $544.47
9/30/20213,430,000 shares $1.88 billion -5.3%3.6%6 $546.86
9/15/20213,620,000 shares $2.00 billion -6.0%3.8%5.6 $551.67
8/31/20213,850,000 shares $2.04 billion -3.3%4.1%5.7 $529.42
8/13/20213,980,000 shares $1.96 billion -5.9%4.2%5.5 $491.41
7/30/20214,230,000 shares $2.18 billion -1.9%4.5%5.4 $515.51
7/15/20214,310,000 shares $1.90 billion +5.6%4.5%5.4 $441.42
6/30/20214,080,000 shares $1.74 billion +6.8%4.3%5.1 $427.00
6/15/20213,820,000 shares $1.55 billion +3.5%4.0%5 $405.10
5/28/20213,690,000 shares $1.36 billion -1.6%3.9%4.8 $369.39
5/14/20213,750,000 shares $1.21 billion +5.3%N/A4.7 $323.96
4/30/20213,560,000 shares $1.50 billion -2.2%N/A4.5 $421.70
4/15/20213,640,000 shares $1.42 billion +2.0%N/A4.8 $391.10
3/31/20213,570,000 shares $1.24 billion -3.0%N/A4.3 $347.20
3/15/20213,680,000 shares $1.32 billion -5.4%N/A4.2 $357.73
2/26/20213,890,000 shares $1.54 billion +2.9%N/A4.2 $395.47
2/12/20213,780,000 shares $1.55 billion +0.5%N/A3.9 $410.20
1/29/20213,760,000 shares $1.38 billion -0.3%N/A3.8 $366.89
1/15/20213,770,000 shares $1.33 billion +9.3%N/A3.2 $352.08
12/31/20203,450,000 shares $1.25 billion -1.2%N/A2.9 $362.77
12/15/20203,490,000 shares $1.23 billion +19.9%N/A3.1 $353.59
11/30/20202,910,000 shares $925.99 million +7.4%N/A2.7 $318.21
11/15/20202,710,000 shares $911.64 million -1.1%N/A2.6 $336.40
10/30/20202,740,000 shares $918.69 million -31.0%N/A2.9 $335.29
10/15/20203,970,000 shares $1.56 billion -4.1%N/A5.1 $394.01
9/30/20204,140,000 shares $1.71 billion +8.4%N/A5.2 $412.23
9/15/20203,820,000 shares $1.52 billion -1.0%N/A4.4 $397.97
8/31/20203,860,000 shares $1.64 billion +1.6%N/A4.1 $425.41

DXCM Short Interest - Frequently Asked Questions

What is DexCom's current short interest?

Short interest is the volume of DexCom shares that have been sold short but have not yet been closed out or covered. As of July 31st, traders have sold 8,490,000 shares of DXCM short. 2.17% of DexCom's shares are currently sold short. Learn More on DexCom's current short interest.

What is a good short interest ratio for DexCom?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. DXCM shares currently have a short interest ratio of 2.0. Learn More on DexCom's short interest ratio.

Which institutional investors are shorting DexCom?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of DexCom: Group One Trading LLC, BNP Paribas Financial Markets, Balyasny Asset Management L.P., Bank of America Corp DE, Jane Street Group LLC, Caption Management LLC, Qube Research & Technologies Ltd, Maven Securities LTD, Walleye Capital LLC, Walleye Trading LLC, Lido Advisors LLC, Hsbc Holdings PLC, Capital Fund Management S.A., Jefferies Financial Group Inc., Eisler Capital Management Ltd., JPMorgan Chase & Co., SG Capital Management LLC, SG Americas Securities LLC, Garda Capital Partners LP, Wolverine Asset Management LLC, and Twin Tree Management LP. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for DexCom?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.17% of DexCom's floating shares are currently sold short.

Is DexCom's short interest increasing or decreasing?

DexCom saw a drop in short interest in July. As of July 31st, there was short interest totaling 8,490,000 shares, a drop of 4.5% from the previous total of 8,890,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does DexCom's short interest compare to its competitors?

2.17% of DexCom's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to DexCom: HealthEquity, Inc. (5.64%), Insulet Corporation (2.50%), Abbott Laboratories (1.06%), AMN Healthcare Services Inc (10.06%), Integer Holdings Corporation (6.80%), Medtronic PLC (0.91%), Becton, Dickinson and Company (1.92%), IDEXX Laboratories, Inc. (3.13%), Edwards Lifesciences Corporation (1.39%), ResMed Inc. (6.20%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.87 billion), Invesco QQQ ($30.12 billion), iShares Russell 2000 ETF ($19.85 billion), iShares 20+ Year Treasury Bond ETF ($10.34 billion), Strategy Inc ($8.98 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.61 billion), SPDR S&P Biotech ETF ($6.81 billion), Invesco S&P 500 Equal Weight ETF ($6.14 billion), Palo Alto Networks, Inc. ($5.97 billion), and Super Micro Computer, Inc. ($5.28 billion). View all of the most shorted stocks.

What does it mean to sell short DexCom stock?

Short selling DXCM is an investing strategy that aims to generate trading profit from DexCom as its price is falling. DXCM shares are trading up $0.26 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against DexCom?

A short squeeze for DexCom occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of DXCM, which in turn drives the price of the stock up even further.

How often is DexCom's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including DXCM, twice per month. The most recent reporting period available is July, 31 2025.




This page (NASDAQ:DXCM) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners